Physician profile
Elena Salerno
NPI 1144204132
$2,125.38
in general payments reported to CMS, 2019-2025
29 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $157 · 2021: $633 · 2022: $466 · 2023: $402 · 2024: $142 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $787.91 | 2019-2024 | Liletta, Lo Loestrin Fe, Orilissa |
| Amgen INC. | $188.47 | 2019-2022 | |
| Bard Access Systems, INC. | $116.48 | 2021 | |
| Mayne Pharma Commercial LLC | $104.61 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $98.76 | 2023-2024 | Myfembree |
| Exeltis, USA INC. | $82.42 | 2021-2025 | Slynd |
| Pfizer INC. | $76.99 | 2019-2023 | |
| Hologic Sales and Service, LLC | $72.74 | 2023-2024 | Novasure, Acessa Provu System, Aptima |
| Mylan Pharmaceuticals INC. | $68.25 | 2021-2022 | |
| Exact Sciences Corporation | $58.58 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $54.50 | 2019-2024 | Veozah |
| Coopersurgical, INC. | $52.75 | 2019-2025 | Paragard T 380a |
| Agile Therapeutics, INC. | $48.13 | 2022 | |
| Allergan, INC. | $44.98 | 2019 | |
| Myovant Sciences INC. | $31.74 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $27.96 | 2025 | Femlyv, Intrarosa |
| Ferring Pharmaceuticals INC. | $23.54 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.52 | 2023 | |
| Biogen, INC. | $18.32 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $17.85 | 2022 | |
| Organon LLC | $17.13 | 2021-2024 | |
| Azurity Pharmaceuticals, INC. | $16.00 | 2023 | Adthyza |
| Radius Health, INC. | $15.18 | 2021 | |
| Scynexis, INC. | $15.08 | 2022 | |
| Smith+Nephew, INC. | $15.00 | 2025 | Pico 7, Pico 14 |
| Dermira, INC. | $14.16 | 2019 | |
| Avion Pharmaceuticals | $13.40 | 2020 | |
| Ascend Therapeutics US, LLC | $13.12 | 2023 | |
| Therapeuticsmd, INC. | $11.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Salerno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.